Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$9,254 Mln
Revenue (TTM)
$6,685 Mln
Net Profit (TTM)
$0 Mln
ROE
0.1 %
ROCE
-- %
P/E Ratio
12.7
P/B Ratio
1.5
Industry P/E
62.68
EV/EBITDA
8.8
Div. Yield
0 %
Debt to Equity
0.5
Book Value
$--
EPS
$1
Face value
--
Shares outstanding
681,430,016
CFO
$4,181.50 Mln
EBITDA
$7,008.10 Mln
Net Profit
$1,514.20 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Avantor (AVTR)
| -39.2 | -1.9 | -17.6 | -38.4 | -23.1 | -6.7 | -- |
|
BSE Sensex*
| 5.6 | 1.9 | 7.7 | 2.4 | 15.4 | 18.0 | 11.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2024
|
2023
|
2022
|
2021
|
2020
|
|---|---|---|---|---|---|
|
Avantor (AVTR)
| -7.6 | 8.3 | -50.0 | 49.7 | 55.1 |
|
S&P Small-Cap 600
| 7.0 | 13.9 | -17.4 | 25.3 | 9.6 |
|
BSE Sensex
| 8.1 | 18.7 | 4.4 | 22.0 | 15.8 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Avantor (AVTR)
|
12.8 | 9,253.8 | 6,685.2 | 715.6 | 16.4 | 12.3 | 12.7 | 1.5 |
| 250.1 | 6,628.2 | 2,541.1 | -2,228.1 | -106.3 | -31.5 | -- | 1.0 | |
| 247.4 | 6,829.1 | 2,541.1 | -2,228.1 | -106.3 | -31.5 | -- | 1.0 | |
| 42.0 | 6,547.7 | 3,446.1 | 79.6 | 7.5 | 4.4 | 83.1 | 3.6 | |
| 98.3 | 5,953.5 | 404.5 | -123.7 | -26.1 | -17.3 | -- | 7.8 | |
| 55.9 | 7,766.7 | 2,510.8 | 185.6 | 8.8 | 4.5 | 42.8 | 1.9 | |
| 70.6 | 8,835.4 | 12,669.0 | 407.0 | 5.4 | 11.8 | 22 | 2.7 | |
| 160.0 | 8,766.7 | 1,973.6 | -494.5 | -11.4 | -41 | -- | 9.3 | |
| 236.4 | 9,267.9 | 1,240.1 | 42.2 | 4.1 | 3.6 | 221.6 | 7.6 | |
| 118.1 | 6,816.7 | 645.7 | -25.4 | 6.8 | -1.3 | -- | 3.7 |
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle... East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania. Address: Radnor Corporate Center, Radnor, PA, United States, 19087 Read more
President, CEO & Director
Mr. Michael Stubblefield
Executive VP & CFO
Mr. R. Brent Jones
Headquarters
Radnor, PA
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Avantor Inc (AVTR) stood at $ 14,361 Mln as on 31-Mar-25
The share price of Avantor Inc (AVTR) is $12.82 (NYSE) as of 15-Jul-2025 16:00 EDT. Avantor Inc (AVTR) has given a return of -23.08% in the last 3 years.
Avantor Inc (AVTR) has a market capitalisation of $ 9,254 Mln as on 15-Jul-2025. As per Value Research classification, it is a Small Cap company.
The P/B ratio of Avantor Inc (AVTR) is 1.48 times as on 15-Jul-2025, a 61% discount to its peers’ median range of 3.82 times.
The P/E ratio of Avantor Inc (AVTR) is 12.71 times as on 15-Jul-2025, a 80% discount to its peers’ median range of 62.68 times.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Avantor Inc (AVTR) and enter the required number of quantities and click on buy to purchase the shares of Avantor Inc (AVTR).
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania. Address: Radnor Corporate Center, Radnor, PA, United States, 19087
The CEO & director of Mr. Michael Stubblefield. is Avantor Inc (AVTR), and CFO & Sr. VP is Mr. R. Brent Jones.
There is no promoter pledging in Avantor Inc (AVTR).
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
946
|
|
|
927
|
|
|
897
|
|
|
766
|
|
|
729
|
|
|
674
|
|
|
674
|
|
|
642
|
|
|
598
|
| Avantor Inc. (AVTR) | Ratios |
|---|---|
|
Return on equity(%)
|
12.28
|
|
Operating margin(%)
|
16.35
|
|
Net Margin(%)
|
10.7
|
|
Dividend yield(%)
|
0
|
No, TTM profit after tax of Avantor Inc (AVTR) was $0 Mln.
$-0.40
(
